Amongst the topics discussed with the representatives of the economic, health and innovation ministries were the Pharmaceutical Market Restructuring Act (AMNOG), advantages and disadvantages with regard to Germany as a business location for the healthcare industries, e-health as well the Federal Government’s ongoing pharmaceuticals dialogue. Due to recent developments, the discussions also focused on the refugee issue and how the health industry can be supportive with regard to this issue. We look forward to continuing these constructive meetings in 2016!
For further information, please contact:
Constanze Krüger, Specialist, Government Relations
T +49 30 288789-27
E ckrueger@amcham.de
